These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G. J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385 [Abstract] [Full Text] [Related]
5. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Manji HK, Chen G. Mol Psychiatry; 2002; 7 Suppl 1():S46-56. PubMed ID: 11986995 [Abstract] [Full Text] [Related]
6. Mood stabilizers: protecting the mood...protecting the brain. Brunello N. J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343 [Abstract] [Full Text] [Related]
7. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Chen G, Manji HK. Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219 [Abstract] [Full Text] [Related]
8. Valproate and neuroprotective effects for bipolar disorder. Atmaca M. Int Rev Psychiatry; 2009 May; 21(4):410-3. PubMed ID: 20374154 [Abstract] [Full Text] [Related]
9. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Chuang DM. Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524 [Abstract] [Full Text] [Related]
10. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Manji HK, Moore GJ, Chen G. Biol Psychiatry; 2000 Oct 15; 48(8):740-54. PubMed ID: 11063971 [Abstract] [Full Text] [Related]
12. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Zarate CA, Singh J, Manji HK. Biol Psychiatry; 2006 Jun 01; 59(11):1006-20. PubMed ID: 16487491 [Abstract] [Full Text] [Related]
16. New understanding of mechanisms of action of bipolar medications. Sanacora G. J Clin Psychiatry; 2008 Apr 15; 69 Suppl 5():22-7. PubMed ID: 19265637 [Abstract] [Full Text] [Related]
17. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P, Gould TD, Manji HK, Chen G. J Neurosci; 2004 Jul 21; 24(29):6590-9. PubMed ID: 15269271 [Abstract] [Full Text] [Related]
18. Neuroplasticity and cellular resilience in mood disorders. Manji HK, Moore GJ, Rajkowska G, Chen G. Mol Psychiatry; 2000 Nov 21; 5(6):578-93. PubMed ID: 11126389 [Abstract] [Full Text] [Related]
19. The efficacy and use of anticonvulsants in mood disorders. Dunn RT, Frye MS, Kimbrell TA, Denicoff KD, Leverich GS, Post RM. Clin Neuropharmacol; 1998 Nov 21; 21(4):215-35. PubMed ID: 9704164 [Abstract] [Full Text] [Related]
20. [Neuroplasticity and depression]. Czéh B, Simon M. Psychiatr Hung; 2005 Nov 21; 20(1):4-17. PubMed ID: 16389729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]